991 – 1000 of 1016
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 1994
-
Mark
Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B
- Contribution to journal › Article
-
Mark
Enhanced ELISA sensitivity using TCA for efficient coating of biologically active lipopolysaccharides or lipid A to the solid phase
- Contribution to journal › Article
-
Mark
Site-directed primary in vitro immunization : Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
- Contribution to journal › Article
-
Mark
Intra- and extracellular expression of an scFv antibody fragment in E. coli : Effect of bacterial strains and pathway engineering using GroES/L chaperonins
- Contribution to journal › Article
-
Mark
Flow cytometric analysis of the stability of antibody production by human × human × mouse heterohybridoma subclones
- Contribution to journal › Article
-
Mark
Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins.
- Contribution to journal › Article
- 1993
-
Mark
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
- Contribution to journal › Article
-
Mark
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
- Contribution to journal › Article
-
Mark
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
- Contribution to journal › Article
